Sunday 20 January 2019
Home      All news      Contact us     
WSJ - 8 days ago

Samsung Faces Resistance From Big Pharma in the U.S.

Samsung’s foray into the U.S. biologic-drug market is proving tougher than expected, as the South Korean company faces strong resistance from established pharmaceutical companies while doctors and patients are reluctant to switch to biosimilars.

Related news

Latest News
Hashtags:   

Samsung

 | 

Faces

 | 

Resistance

 | 

Pharma

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources